MedTrace Logo

Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients

NCT04563689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2020-11-20

No results posted yet for this study

Summary

Randomized, double-blind, placebo-controlled pilot study to evalaute viral load in saliva of COVID19+ patients using quantitative PCR, before and after use of active or placebo rinses

Conditions

  • Covid19

Interventions

OTHER

CHX0.12+CPC0.05 oral rinse (PerioAidActive Control)

rinse 15 ml during 1 min during 5 days, twice daily

OTHER

placebo rinse

destilled water rinse 15 ml during 1 min during 5 days, twice daily

Sponsors & Collaborators

  • Dentaid SL

    lead INDUSTRY

Principal Investigators

  • Ruben Leon, PhD · Dentaid SL

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2020-10-22
Completion
2020-10-23

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04563689 on ClinicalTrials.gov